<DOC>
	<DOCNO>NCT00309244</DOCNO>
	<brief_summary>The purpose 13 month study ( 12 month treatment period 1 month follow-up period ) determine whether inhaled insulin safe effective treatment type 2 diabetes .</brief_summary>
	<brief_title>Efficacy Safety Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin Prandial Inhalation Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over 52-Week Treatment Period 4-Week Follow-up</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Men woman ≥ 18 ≤ 80 year old Clinical diagnosis type 2 diabetes mellitus HbA1c &gt; 7.0 % ≤ 11.0 % BMI ≤ 40 kg/m2 Negative smoking status urine cotinine test Written inform consent Receiving sc insulin 23 time daily administer follow 3 regimen : selfmix regimen , premix regimen , longacting analogue regular rapidacting insulin analogue exceed 3 daily injection . Subjects may also receive oral antidiabetic agent include metformin thiazolidinediones . No dose adjustment insulin oral antidiabetic agent within precede 6 week . FEV1 ≥ 70 % NHANES III predict ; TLC ) ≥ 80 % predict ( Intermountain Thoracic Society ) ; DLCO uncorrected ≥ 70 % predict Total daily dose insulin ≥1.4 IU/kg body weight Treatment sulfonylurea and/or meglitinides and/or alphaglucosidase inhibitor within precede 8 week Treatment pramlintide acetate ( Symlin® ) , and/or incretins ( e.g. , exenatide [ Byetta® ] ) within precede 8 week Unstable diabetes mellitus control , define 2 episode severe hypoglycemia ( require third party intervention ) and/or hospitalization emergency room visit due poor diabetic control hyperglycemia require hospitalization within precede 6 month Exposure inhale insulin time , treatment investigational drug within precede 3 month , and/or current participation another clinical trial Allergy insulin drug use part clinical trial , history hypersensitivity investigational drug drug similar chemical structure History active viral and/or cirrhotic hepatic disease and/or abnormal liver enzyme evidence serum aspartate aminotransferase ( AST ) and/or alanine aminotransferase ( ALT ) ≥ 3 x Upper Limit Normal ( ULN ) ( Includes active hepatitis A , positive hepatitis B and/or hepatitis C serology ) Serum creatinine &gt; 1.8 mg/dL woman &gt; 2.0 mg/dL men History chronic obstructive pulmonary disease ( COPD ) , asthma ( history bronchospasm asthma age 14 ) , and/or clinically important pulmonary disease confirm documented history , pulmonary function testing , radiologic finding Congestive heart disease grade class III class IV accord New York Heart Association criterion subject currently treat pharmacologically ventricular dysrhythmias use amiodarone History myocardial infarction , cardiac surgery , coronary angioplasty , and/or stroke within precede 3 month Symptomatic coronary artery disease , include crescendo angina , unstable angina , and/or unstable symptomatic cardiac arrhythmia Poorly control arterial hypertension despite pharmacologic treatment , define systolic blood pressure ( BP ) &gt; 180 mm Hg and/or diastolic BP &gt; 110 mm Hg screen History malignancy within precede 5 year ( excise basal cell carcinoma skin ) , history lung neoplasm , and/or subject current previous chemotherapy radiation therapy may result pulmonary toxicity History acquire immunodeficiency syndrome ( AIDS ) , AIDSrelated complex ( ARC ) , positive human immunodeficiency virus ( HIV ) serology Prior diagnosis systemic autoimmune collagen vascular disease require previous current treatment systemic corticosteroid , cytotoxic drug , penicillamine Visit 1/Screening ( Week 3 ) , prior Visit 1 PFTs Visit 3/Baseline ( Week 0 ) , subject schedule PFTs 30 day resolution respiratory infection . An additional hemoglobin urine βHCG ( woman childbearing potential age ) require Women pregnant , lactate plan become pregnant Women childbearing potential ( define premenopausal surgically sterilize postmenopausal le 2 year ) practice adequate birth control . Adequate birth control define use oral , percutaneous and/or transdermal contraceptive ; condom diaphragms spermicide , intrauterine device Current drug and/or alcohol abuse Subjects opinion Investigator unable comply requirement protocol Severe complication diabetes mellitus , opinion Investigator , include : symptomatic autonomic neuropathy , disable peripheral neuropathy , active proliferative retinopathy ; nephropathy renal failure , renal transplant and/or dialysis ; history foot ulcer ; nontraumatic amputation due gangrene ; and/or vascular claudication Any concurrent medical major psychiatric condition , opinion Investigator , make subject unsuitable clinical trial , could limit validity ICF and/or impair subject 's ability participate trial Inability perform PFT maneuver meet recommended American Thoracic Society ( ATS ) acceptability repeatability criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>